Clinical trials
Approved for marketing Lipid Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1 trial matches Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ionis Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 1 |
| Genetic Diseases, Inborn | 1 |
| Hyperlipidemias | 1 |
| Hyperlipoproteinemia Type I | 1 |
| Hyperlipoproteinemias | 1 |
| Lipid Metabolism Disorders | 1 |
| Lipid Metabolism, Inborn Errors | 1 |
| Metabolic Diseases | 1 |
| Metabolism, Inborn Errors | 1 |
Trials
Showing 76 to 1 of 1. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.